To cite this paper use one of the standards below:
Hepatotoxicity is a key concern for developing new drugs since it is difficult to anticipate in the early stages of drug discovery due from pharmacologically unrelated drug effects (i.e., drug accumulation, metabolism, and pathway interference). 1,2 Despite that, the reliable prediction of hepatic adverse effects using traditional single-task learning (STL) approaches is a substantial challenge in clinical development. Here, we developed a multitask learning (MTL) strategy based on inductive transfer of knowledge to simultaneously predict LOAEL values of untested compounds for several clinical hepatotoxicity endpoints. Initially, a dataset comprising 1083 compounds with hepatic adverse effects in humans was collected from various sources. The complex pathology was clustered into 15 clinical hepatotoxicity endpoints. Then, an MTL model was developed using a Feedforward Neural Network (FNN) architecture and molecular fingerprints (ECFP4). The best MTL model significantly outperforms past STL methods, with acceptable average RMSE values (train ~0.24, validation ~0.62, test ~0.65).
Con casi 200.000 artículos publicados, Galoá permite a los académicos compartir y descubrir investigaciones de vanguardia a través de nuestra plataforma de publicación académica optimizada y accesible.
Obtenga más información sobre nuestros productos:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Atención: este no es un DOI para el trabajo y, como tal, no se puede usar en Lattes para identificar un trabajo en particular.
Check the link "How to cite" en la página del papel, para ver cómo citar correctamente el papel